Suchergebnisse
Suchergebnisse:
The original New York Cancer Hospital [2] built between 1884 and 1886, now housing, at 455 Central Park West and 106th Street in Manhattan. Memorial Sloan Kettering Cancer Center ( MSK or MSKCC) is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital.
immuno-oncology. [ edit on Wikidata] Cancer immunotherapy ( immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology) and a growing subspecialty of oncology .
Small-cell carcinoma of the lung usually presents in the central airways and infiltrates the submucosa leading to narrowing of bronchial airways. Common symptoms include cough, dyspnea, weight loss, and debility. Over 70% of patients with small-cell carcinoma present with metastatic disease; common sites include liver, adrenals, bone, and brain.
Online archive. The Journal of the National Cancer Institute ( JNCI) is a peer-reviewed medical journal covering research in oncology that was established in August 1940. It is published monthly by Oxford University Press and is edited by Patricia A. Ganz. It was merged with Cancer Treatment Reports in January 1988.
Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder. [1] Symptoms include blood in the urine, pain with urination, and low back pain. [1] It is caused when epithelial cells that line the bladder become malignant. [4]
659,853 (2022) [9] Stomach cancer, also known as gastric cancer, is a cancer that develops from the lining of the stomach. [10] Most cases of stomach cancers are gastric carcinomas, which can be divided into a number of subtypes, including gastric adenocarcinomas. [2] Lymphomas and mesenchymal tumors may also develop in the stomach. [2]
Oncology. Non-small-cell lung cancer ( NSCLC ), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. [1] [2] [3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma.
